Secondary Logo

Journal Logo

May 2016 - Volume 26 - Issue 5
pp: 197-253

HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury

Nicoletti, Paola; Werk, Anneke N.; Sawle, Ashley; More

Pharmacogenetics and Genomics. 26(5):218-224, May 2016.

Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population

Tassaneeyakul, Wichittra; Prabmeechai, Napat; Sukasem, Chonlaphat; More

Pharmacogenetics and Genomics. 26(5):225-234, May 2016.

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients

Drögemöller, Britt I.; Emsley, Robin; Chiliza, Bonginkosi; More

Pharmacogenetics and Genomics. 26(5):235-242, May 2016.

Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma

Vos, Hanneke I.; Guchelaar, Henk-Jan; Gelderblom, Hans; More

Pharmacogenetics and Genomics. 26(5):243-247, May 2016.